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Abstract
Background: In 2010, Brazil recorded 3343,599 cases of malaria, with 99.6% of them concentrated in the
Amazon region. Plasmodium vivax accounts for 86% of the cases circulating in the country. The extra-Amazonian
region, where transmission does not occur, recorded about 566 cases imported from the Amazonian area in
Brazil and South America, from Central America, Asia and African countries. Prolonged incubation periods have
been described for P. vivax malaria in temperate climates. The diversity in essential biological characteristics is
traditionally considered as one possible explanation to the emergence of relapse in malaria and to the
differences in the duration of the incubation period, which can also be explained by the use of
chemoprophylaxis. Studying the reported cases of P. vivax malaria in Rio de Janeiro, where there is no vector
transmission, has made it possible to evaluate the extension of the incubation period and to notice that it may
be extended in some cases.
Methods: Descriptive study of every malaria patients who visited the clinic in the last five years. The mean,
standard deviation, median, minimum and maximum of all incubation periods were analysed.
Results: From the total of 80 patients seen in the clinic during the study time, with confirmed diagnosis of
malaria, 49 (63%) were infected with P. vivax. Between those, seven had an estimated incubation period varying
from three to 12 months and were returned travellers from Brazilian Amazonian states (6) and Indonesia (1). None
of them had taken malarial chemoprophylaxis.
Conclusions: The authors emphasize that considering malaria as a possible cause of febrile syndrome should be a
post-travel routine, independent of the time elapsed after exposure in the transmission area, even in the absence
of malaria chemoprophylaxis. They speculate that, since there is no current and detailed information about the
biological cycle of human malaria plasmodia’s in Brazil, it is possible that new strains are circulating in endemic
regions or a change in cycle of preexisting strains is occurring. Considering that a prolonged incubation period
may confer advantages on the survival of the parasite, difficulties in malaria control might arise.
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Background
The malaria incubation period is defined as the time
elapsed between exposure to the infectious agent
(through the bite of the Anopheles mosquito) and the
manifestation of the first clinical sign or symptom.
Usually, these periods vary depending on the species of
Plasmodium causing malaria. The average incubation
period is 9-14 days for Plasmodium falciparum, 12-17
days for infections by Plasmodium vivax and 18-40 days
for infections caused by Plasmodium malariae [1].
The relapse patterns and variations in the length of
the incubation period, including a delay of four months
or longer, was first described by Korteweg in Holland
between 1901 and 1902 (cited by Swellengrebel and De
Buck [2]). Later, in 1935, Nikolaev proposed that there
were two strains of P. vivax (cited by Tiburskaya [3])
with different incubation periods and gave the sub-spe-
cific taxonomic name of P. vivax hibernans to the vari-
ety with the longest incubation period. It was suggested
that this sub-species had adapted to more northern lati-
tudes where the anopheles vector was absent for much
of the year. Shute (1946) [4] proposed that the sporo-
zoite infective inoculum would be inversely related to
the prepatent and incubation period. However, in Mos-
cow, Tiburskaya [3] demonstrated situations in which
the length of the incubation period did not depend on
the number of inoculated sporozoites, but instead was
determined by the inherent properties of the strains. It
was also believed that strains with prolonged latency
could be attributed either to the “senility” of the sporo-
zoite towards the end of the season or to the low num-
ber of sporozoites in the infective bite [5].
According to Shute [5], the differences between the P.
vivax strains could be explained by the assumption that,
in varying proportions, all strains of P. vivax produce
two types of sporozoites: one eliciting short prepatent
periods (Type I) and the other lying dormant or devel-
oping slowly to give rise to long prepatent periods
(Type II). In this model, the latter type would greatly
predominate in “temperate strains”, but not in tropical
ones. It was thought that relapses of P. vivax could in
reality correspond to a delayed parasitaemia arising
from Type II sporozoites. In the same year, Garnham
stated that the length of the incubation period was con-
sidered the major biological difference between Dutch,
Madagascar, and USSR strains, and although there was
no evidence of specifically dormant forms, it was
believed that if certain sporozoites failed to develop in
the normal time, they could be reactivated by an
unknown factor one year or more after inoculation [6].
In 1980, Warwick [7] proposed that the ambient winter
temperatures could extend the incubation period of P.
vivax in humans, based on the concept that temperatures
persistently above a minimum of 23.9°C were required
for sporozoite maturation [8], thereby limiting vector
transmission in cold areas. Finally, in 2007, Nishiura et al
in Korea [9] suggested that the incubation periods would
likely reflect adaptation to the behaviour of the principal
vector of the region, which hibernates during the winter
season. Currently, several reports associate the extension
of the incubation period to malaria prophylaxis among
travellers [10,11].
The opportunity to study some cases of P. vivax
malaria in Rio de Janeiro, where there is no vector
transmission, has made it possible to detect and to eval-
uate certain peculiar aspects of the natural evolution of
the disease in human beings. One main aspect was the
extension of time required for the parasites to progress
through liver schizogony and produce symptoms by
their propagation in the bloodstream.
Plasmodium vivax infections with prolonged periods
of incubation and no association with malaria prophy-
laxis in patients from the Amazon region in Brazil and
in one patient from Indonesia are presented.
In addition to demonstrating an interesting clinical
situation and the need for clinicians to consider the
diagnosis of malaria in a patient presenting symptoms a
long time after exposure, even in the absence of chemo-
prophylaxis, our cases raise questions regarding the
understanding of the biology of the host/P. vivax
interactions.
Methods
Design and study location
This is a descriptive study conducted at the Acute Feb-
rile Disease Outpatient Clinics of IPEC, Fiocruz, a spe-
cialized post-travel care clinic located in Rio de Janeiro,
from January, 2005, to February, 2010.
Selection of patients
All malaria patients presenting clinical signs or symp-
toms of malaria and positive thick blood smears were
enrolled in the study. The following variables of interest
were recorded: estimated incubation period, place and
year of infection, date of diagnosis, previous malaria his-
tory and year of the first malarial infection. No patients
had malaria prophylaxis, had not received blood transfu-
sions nor had close contact with a person with malaria
after departure from the endemic area. No patients had
haemoglobinopathies. Because it was not possible to
determine the date of exposure to the infective mos-
quito bites, the minimum incubation period was esti-
mated based on literature (9 days for P. falciparum and
12 days for P. vivax) [1]. The maximum was estimated
by the interval between the day of the return from the
malaria transmission area until the first day of
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symptoms. The mean, standard deviation, median, mini-
mum and maximum of all incubation periods are shown
in Table 1. Each patient gave fully informed consent.
Children were not included.
The project was submitted and approved by the Ethi-
cal Committee in Research of the Instituto de Pesquisa
Clínica Evandro Chagas (IPEC), Fiocruz (number
0020.0.009.000-07), maintaining strict secrecy and confi-
dentiality of the information obtained.
Detection and quantification of malaria parasites
Thin and thick blood smears were stained with Giemsa
and analysed by light microscopy using an immersion
oil lens (X100 objective magnification) to identify the
parasite species and determine the density of Plasmo-
dium asexual and sexual stages, according to standard
procedures [12]. Each smear was evaluated separately by
two expert microscopists who had been blinded to the
clinical status of the patients.
Data analysis
All information was recorded on a standardised form for
study and subsequently entered into a database using
Statistical Package for Social Sciences (SPSS). SPSS-
WIN 16.0 was also used for data analysis.
Results
During the study period, 80 malarious patients were
diagnosed and treated. Of them, 50 (62.5%) presented
with P. vivax malaria, 20 (25%) with P. falciparum
malaria, eight (10%) with mixed (P. vivax/P. falciparum)
infection and two (2.5%) with P. malariae. All patients
were travellers, most of them (51) from the Amazon
region, in Brazil; 17 travelled from Africa, 11 were from
South and Central America, and one was from
Indonesia.
Time between the day of return from the malaria
transmission area and the first day of onset of symptoms
recorded for all patients diagnosed in the Acute Febrile
Diseases Clinic Rio de Janeiro (2005 until January 2010)
was four times longer for P.vivax than for Plasmodium
falciparum and is illustrated in Table 1. The estimated
mean incubation period for all cases was 31 days (SD 51
days), with a median of 12 days and extreme values of 9
and 360 days.
An estimated incubation period longer than 90 days
was observed in seven (14%) of the patients with P.
vivax malaria (Figure 1). The average incubation period
(147 days) among this group was about twelve times
longer than the classical period described in the litera-
ture (12 days). Malaria was contracted during visits to
the Amazonian region (in six cases) and Indonesia (in
one). Their details are described in Table 2. There were
no differences in clinical presentation between indivi-
duals with P. vivax infection with different incubation
periods. No patient had undergone malaria chemopro-
phylaxis or had taken any pharmacological drug that
could inhibit the parasite’s development.
Discussion
This is the second report of prolonged incubation per-
iod of malaria in patients without chemoprophylaxis
coming from an endemic area in Brazil. A recent paper
by one of the authors of this report (Tauil PL) described
three cases of vivax malaria originating from the Ama-
zon region and diagnosed in Brasilia, Federal District,
six months after departure from the endemic region in
2008 [13]. Two of those patients were infected in the
same town (São Gabriel da Cachoeira, Amazonas State,
Brazil), as one of the patients in the present study. Some
of the cases in this study were detected in 2005 and
2006, prior to the cases detected in Brasilia and reported
by Tauil et al [13]. All possible current explanations for
Table 1 Time between the day of the return from the
malaria transmission area and the first day of onset of
symptoms of malaria cases diagnosed in the Acute Febrile
Diseases Clinic, Rio de Janeiro (2005 until January 2010)
P. vivax P. falciparum Mixed Infection
(P. vivax and
P. falciparum)
Mean 45 d 10 d 11 d
Standard
Deviation
67 d 16 d 7 d
Median 25 d 6 d 12 d
Maximum 360 d 60 d 18 d
Minimum 12 h 12 h 12 d
d = days; h = hours
Figure 1 Estimated incubation period in days for each P. vivax
infected patient.
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these prolonged periods (use of malaria prophylaxis or
other pharmacological drugs that would inhibit the Plas-
modium development; blood transfusions; close contact
with a person with malaria after departure from the
endemic area or haemoglobinopathies) were eliminated.
The observation of a longer incubation period (≥90
days) in 14% of the P. vivax malaria patients seen at
IPEC, in Rio de Janeiro, may indicate the importance of
monitoring these characteristics worldwide, as it may
represent an evolutionary change in P. vivax behaviour.
The average incubation period of P. vivax malaria pre-
sented here was approximately twelve times longer than
the classical period described in the literature. In this
study, the extended incubation time occurred in both
prime-infected (130 days) and non-prime-infected (131
days) patients, so the possibility of relapse among non-
prime-infected patients cannot be ruled out. However,
in two patients previously infected with malaria, the per-
iod between the last infection and the current clinical
manifestation was five and six years, by far exceeding
the maximum period of relapse reported for P. vivax
(three years) [14]. Cities such as Rio de Janeiro, as well
as areas in the northern hemisphere without disease
transmission may be considered strategic places for
monitoring incubation period, clinical cures and treat-
ment failure in cases of malaria, facilitating the identifi-
cation of the above features without misinterpreting
variations as the result of new infections.
During the five years of surveillance (2005-2010) no
seasonal differences in the prevalence of clinical P. vivax
malaria diagnosed outside the endemic area were
observed between these cases with prolonged incubation
periods. Regardless, the postulate that extended incuba-
tion periods may represent an adaptation of the species
to overcome cold temperatures, thereby conferring
advantages for the survival of the parasite, does not
seem to fit the reality of tropical areas, where the tem-
perature is rarely below 10°C. Although the role of
strain-specific variation in prolonged incubation periods
has been questioned by some authors [9], it is possible
that new strains of Plasmodium are circulating in
tropical areas, especially in the Amazon, which is a
region frequently visited by foreigners and which has
seen the movements of troops.
Fever is one of the most common clinical signs in
returning travellers [15-20]. The incubation periods of
potential pathogens should be considered when formu-
lating differential diagnoses. The geographic location(s)
visited, the traveller’s activities and the frequency of spe-
cific diseases in the region are usually taken into account.
According to the observations reported here, malaria
should be considered among the diseases with longer
incubation periods (weeks to months after return), even
in patients without malaria chemoprophylaxis.
Conclusions
It is classically considered that the co-existence of short
and long-term incubation periods may imply that prolon-
gation of this phase is either a genetically regulated fea-
ture of parasites or is controlled within Anopheles spp. by
mechanisms yet to be defined. Therefore, new molecular
tools need to be used for investigation of biological char-
acteristics and origin of the Plasmodium strains that pre-
sents a prolonged incubation time in Brazilian patients
that have never visited the temperate zone.
Plasmodium vivax, responsible for 86% of malaria
cases in Brazil [21], has long been neglected and mista-
kenly [22]. The change in incubation period reported
here is particularly important in theory, because it raises
the possibility of changes in the biology and evolution of
this organism, entering into strategic debates taking
place on malaria epidemiology and control; and in prac-
tice because malaria is one of the most important infec-
tious diseases among travellers and a long incubation
period is one of the causes of missing early malaria
diagnosis.
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Table 2 Patients with P. vivax infection and estimated incubation period ≥ 90 days
Departure from
endemic area
Date of initial symptoms
(days after departure)
Possible local of infection Previous malaria Year of previous infection Relapse
Patient 1 06/30/2007 07/31/2008 (360) Indonesia Yes 2007 Yes
Patient 2 12/12/2005 04/23/2006 (131) Rondonia State, Brazil Yes 2001 Unknown
Patient 3 12/3/2007 04/12/2008 (130) Amazonas State, Brazil No NA No
Patient 4 02/9/2005 06/16/2006 (120) Roraima State, Brazil Yes 2000 Unknown
Patient 5 12/6/2007 03/24/2008 (108) Amapa State, Brazil Yes 2007 Yes
Patient 6 07/5/2006 10/9/2006 (95) Para State, Brazil Yes 2006 Yes
Patient 7 06/15/2005 09/15/2005 (90) Para State, Brazil Not Avaiable Not Avaiable Unknown
NA = non aplicable
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